12-132620010-T-G

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM2BP4_StrongBP7

The NM_170682.4(P2RX2):​c.468T>G​(p.Thr156Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Synonymous variant affecting the same amino acid position (i.e. T156T) has been classified as Benign.

Frequency

Genomes: not found (cov: 33)

Consequence

P2RX2
NM_170682.4 synonymous

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -9.34

Publications

0 publications found
Variant links:
Genes affected
P2RX2 (HGNC:15459): (purinergic receptor P2X 2) The product of this gene belongs to the family of purinoceptors for ATP. This receptor functions as a ligand-gated ion channel. Binding to ATP mediates synaptic transmission between neurons and from neurons to smooth muscle. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Aug 2013]
P2RX2 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 41
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_170682.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (REVEL=0.002).
BP7
Synonymous conserved (PhyloP=-9.34 with no splicing effect.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_170682.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
P2RX2
NM_170682.4
MANE Select
c.468T>Gp.Thr156Thr
synonymous
Exon 5 of 11NP_733782.1Q9UBL9-1
P2RX2
NM_170683.4
c.468T>Gp.Thr156Thr
synonymous
Exon 5 of 10NP_733783.1Q9UBL9-4
P2RX2
NM_016318.4
c.396T>Gp.Thr132Thr
synonymous
Exon 4 of 10NP_057402.1Q9UBL9-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
P2RX2
ENST00000643471.2
MANE Select
c.468T>Gp.Thr156Thr
synonymous
Exon 5 of 11ENSP00000494644.1Q9UBL9-1
P2RX2
ENST00000343948.8
TSL:1
c.468T>Gp.Thr156Thr
synonymous
Exon 5 of 10ENSP00000343339.4Q9UBL9-4
P2RX2
ENST00000350048.9
TSL:1
c.396T>Gp.Thr132Thr
synonymous
Exon 4 of 10ENSP00000343904.5Q9UBL9-3

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
43
GnomAD4 genome
Cov.:
33

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.66
CADD
Benign
0.11
DANN
Benign
0.64
PhyloP100
-9.3

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

hg19: chr12-133196596;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.